查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1574984

慢性病管理市場，按平台類型、服務類型、疾病類型、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Chronic Disease Management Market, By Platform Type, By Service Type, By Disease Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年慢性病管理市場規模為51.0932億美元，2024年至2032年複合年成長率為14.90%。

慢性病管理市場-市場動態

對預防性醫療保健的日益重視推動了慢性病管理市場的擴大

隨著組織和政府越來越認知到早期介入和持續照護的重要性，對預防性醫療保健的日益重視正在顯著推動慢性病管理市場的擴張。根據美國疾病管制與預防中心 (CDC) 的數據，慢性病占美國 10 大死因中的 7 個，凸顯了有效管理策略的迫切需求。美國國立衛生研究院的一項研究發現，生活方式的改變和預防措施可以將慢性病的風險降低80%。此外，世界衛生組織全球行動計畫等措施的目標是到 2025 年將非傳染性疾病造成的過早死亡率降低 25%，這強化了以預防為重點的全面慢性病管理計畫的必要性。

慢性病管理市場-關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 14.90% 左右的複合年成長率成長

根據平台類型細分，預計基於雲端的解決方案將在 2023 年顯示最大的市場佔有率

根據服務類型細分，2023年護理協調為主導類型

依疾病類型細分，2023年心血管疾病為主導類型

按地區分類，北美是 2023 年的主要收入來源

慢性病管理市場-細分分析：

全球慢性病管理市場根據平台類型、服務類型、疾病類型、最終用戶和地區進行細分。

根據平台類型，市場分為三類：基於網路的解決方案、基於雲端的解決方案和本地解決方案。基於雲端的解決方案因其可擴展性和可訪問性而受到歡迎，其次是基於網路的解決方案，為患者和提供者提供方便用戶使用的介面。本地解決方案排名第三，主要由大型醫療機構用於資料安全。

根據服務類型，市場分為四個類別：諮詢、護理協調、教育和培訓以及監測和評估。護理協調服務因其在患者管理中的關鍵作用而被優先考慮，其次是確保持續評估的監測和評估服務。諮詢排名第三，而教育和培訓服務對於增強患者能力至關重要。

慢性病管理市場-地理洞察

慢性病管理市場呈現多樣化的地理動態，在高醫療保健支出和先進基礎設施的推動下，北美處於領先地位。在美國，疾病預防控制中心的國家糖尿病預防計畫等措施已成功地將參與者的糖尿病發生率降低了 58%。歐洲緊隨其後，德國和英國等國家正在優先考慮綜合護理模式以有效管理慢性病，NHS 對糖尿病管理計劃的承諾證明了這一點，該計劃旨在改善超過 100 萬名患者的治療結果。在意識不斷提高和老年人口不斷增加的推動下，亞太地區正在迅速崛起；例如，日本厚生勞動省實施了一項獨特的健康管理舉措，針對肥胖和代謝症候群，以對抗慢性病。在拉丁美洲，巴西正在努力建立更具預防性的醫療保健模式，重點是解決高血壓和糖尿病問題的公共衛生運動。最後，中東和非洲對醫療保健技術的投資不斷增加，旨在透過遠距醫療服務和社區健康計畫加強慢性病管理。

慢性病管理市場-競爭格局：

慢性病管理市場的競爭格局是由各個地區的主要參與者塑造的，每個參與者都積極致力於改善病患照護。北美仍處於領先地位，聯合健康集團和信諾等公司投資於創新的數位健康平台，以簡化慢性病管理； CMS 長期照護管理計劃等措施已成功招募了超過 30 萬名醫療保險受益人，以改善照護協調。在歐洲，拜耳和賽諾菲等主要參與者在歐盟衛生計劃的支持下重點關注綜合護理模式，該計劃旨在到2025 年將慢性病患病率降低20%。推出了遠距醫療服務，在澳洲等國家，疫情期間使用量增加了 140%。拉丁美洲也正在興起，巴西的「Saude na Hora」等措施旨在為服務不足的社區提供可及的慢性病管理服務。同時，在西門子醫療等公司的推動下，中東和非洲對醫療保健技術的投資不斷增加，從而增強了該地區獲得醫療服務的機會並改善了管理策略。

最新進展：

2024 年 1 月，亞馬遜與 Omada Health 合作推出了一項慢性病管理計劃，為使用者提供糖尿病和體重管理服務。該計劃旨在幫助消費者透過亞馬遜平台獲得符合資格的福利，提高醫療保健的可近性

2022 年 2 月，Teladoc Health 推出了慢性護理完整計劃，針對糖尿病、糖尿病前期和高血壓管理。該計劃包括連網設備、個人健康教練和心理健康支持，可透過健康計劃或雇主提供，以加強患者護理和管理。

目錄

第1章：慢性病管理市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按平台類型分類的慢性病管理市場片段
    • 按服務類型分類的慢性病管理市場片段
    • 按疾病類型分類的慢性病管理市場片段
    • 最終使用者的慢性病管理市場片段
    • 按國家/地區分類的慢性病管理市場片段
    • 按地區分類的慢性病管理市場片段
  • 競爭洞察

第 3 章：慢性病管理主要市場趨勢

  • 慢性病管理市場促進因素
    • 市場促進因素的影響分析
  • 慢性病管理市場限制
    • 市場限制影響分析
  • 慢性病管理市場機會
  • 慢性病管理市場未來趨勢

第4章：慢病管理產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：慢性病管理市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：慢性病管理市場格局

  • 2023 年慢性病管理市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：慢性病管理市場 - 依平台類型

  • 概述
    • 按平台類型分類的細分市場佔有率分析
    • 網路為基礎的解決方案
    • 基於雲端的解決方案
    • 本地解決方案

第 8 章：慢性病管理市場 - 按服務類型

  • 概述
    • 按服務類型分類的細分市場佔有率分析
    • 諮詢
    • 護理協調
    • 教育與培訓
    • 監測與評估

第 9 章：慢性病管理市場 - 按疾病類型

  • 概述
    • 按疾病類型分類的細分市場佔有率分析
    • 糖尿病
    • 心血管疾病
    • 呼吸系統疾病
    • 癌症
    • 其他

第 10 章：慢性病管理市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院和診所
    • 居家護理
    • 診斷中心
    • 付款人

第 11 章：慢性病管理市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美慢性病管理主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按平台類型）
    • 北美市場規模和預測（按服務類型）
    • 北美市場規模和預測（按疾病類型）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲慢性病管理主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按平台類型）
    • 歐洲市場規模和預測（按服務類型）
    • 歐洲市場規模與預測（按疾病類型）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區慢性病管理主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依平台類型）
    • 亞太地區市場規模與預測（按服務類型）
    • 亞太地區市場規模與預測（按疾病類型）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲慢性病管理主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模和預測（按平台類型）
    • 拉丁美洲市場規模和預測（按服務類型）
    • 拉丁美洲市場規模與預測（按疾病類型）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲慢性病管理主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按平台類型）
    • 中東和非洲市場規模及預測（按服務類型）
    • 中東和非洲市場規模及預測（按疾病類型）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第12章：主要供應商分析-慢性病管理產業

  • 競爭儀表板
  • 公司簡介
    • Allscripts Healthcare Solutions, Inc.
    • Altruista Health, Inc.
    • Cerner Corporation
    • Cognizant Technology Solutions Corporation
    • Epic Systems Corporation
    • GE Healthcare
    • Health Catalyst, Inc.
    • i2i Population Health
    • IBM Corporation
    • Infosys Limited
    • Koninklijke Philips NV
    • McKesson Corporation
    • Medtronic plc
    • Pegasystems Inc.
    • Siemens Healthineers AG
    • ZeOmega, Inc.
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3993

REPORT HIGHLIGHT

Chronic Disease Management Market size was valued at USD 5,109.32 Million in 2023, expanding at a CAGR of 14.90% from 2024 to 2032.

The Chronic Disease Management Market encompasses various strategies and technologies designed to improve health outcomes for individuals with chronic conditions. Chronic disease management involves the ongoing care and support of patients with long-term illnesses like diabetes, hypertension, and heart disease, with approximately 60% of adults in the U.S. living with at least one chronic condition. Rising healthcare costs, an aging population, and increasing awareness about preventive healthcare are significant factors propelling the demand for chronic disease management solutions. However, challenges such as high implementation costs, lack of skilled professionals, and patient non-compliance can hinder market growth. On the flip side, opportunities abound in the form of advancements in telemedicine, the growing integration of artificial intelligence in healthcare, and the increasing focus on personalized medicine, which can enhance the effectiveness of chronic disease management programs and improve patient adherence.

Chronic Disease Management Market- Market Dynamics

Growing Emphasis on Preventive Healthcare Fuels Expansion of the Chronic Disease Management Market

The growing emphasis on preventive healthcare is significantly driving the expansion of the Chronic Disease Management Market, as organizations and governments increasingly recognize the importance of early intervention and ongoing care. According to the Centers for Disease Control and Prevention (CDC), chronic diseases account for 7 of the 10 leading causes of death in the United States, highlighting the urgent need for effective management strategies. A study by the National Institute of Health found that lifestyle changes and preventive measures could reduce the risk of developing chronic diseases by 80%. Furthermore, initiatives like the World Health Organization's Global Action Plan aim to reduce premature mortality from non-communicable diseases by 25% by 2025, reinforcing the necessity for comprehensive chronic disease management programs that focus on prevention.

Chronic Disease Management Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.90% over the forecast period (2024-2032)

Based on Platform Type segmentation, Cloud-based solutions was predicted to show maximum market share in the year 2023

Based on Service Type segmentation, Care coordination was the leading type in 2023

Based on Disease Type segmentation, cardiovascular diseases was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Chronic Disease Management Market- Segmentation Analysis:

The Global Chronic Disease Management Market is segmented on the basis of Platform Type, Service Type, Disease Type, End-User, and Region.

The market is divided into three categories based on Platform Type: Web-Based Solutions, Cloud-Based Solutions, and On-Premise Solutions. Cloud-based solutions lead in popularity due to their scalability and accessibility, followed by web-based solutions that offer user-friendly interfaces for patients and providers. On-premise solutions rank third, primarily used by large healthcare organizations for data security.

The market is divided into Four categories based on Service Type: Consulting, Care Coordination, Education & Training, and Monitoring & Assessment. Care coordination services are prioritized for their critical role in patient management, followed by monitoring and assessment services that ensure ongoing evaluation. Consulting ranks third, while education and training services are essential for empowering patients.

Chronic Disease Management Market- Geographical Insights

The Chronic Disease Management Market exhibits diverse geographical dynamics, with North America leading the charge, driven by high healthcare expenditure and advanced infrastructure. In the U.S., initiatives like the CDC's National Diabetes Prevention Program have successfully reduced diabetes incidence among participants by 58%. Europe follows closely, where countries like Germany and the UK are prioritizing integrated care models to manage chronic diseases effectively, as evidenced by the NHS's commitment to diabetes management programs, which aim to improve outcomes for over 1 million patients. The Asia-Pacific region is rapidly emerging, fueled by rising awareness and a growing elderly population; for instance, Japan's health ministry has implemented a unique health management initiative targeting obesity and metabolic syndrome to combat chronic diseases. In Latin America, Brazil is working towards a more preventive healthcare model, focusing on public health campaigns to address hypertension and diabetes. Lastly, the Middle East and Africa are seeing increasing investment in healthcare technology, with initiatives aimed at enhancing chronic disease management through telehealth services and community health programs.

Chronic Disease Management Market- Competitive Landscape:

The competitive landscape of the Chronic Disease Management Market is shaped by key players across various regions, each actively working to enhance patient care. North America remains a leader, with companies like UnitedHealth Group and Cigna investing in innovative digital health platforms to streamline chronic disease management; initiatives such as the CMS Chronic Care Management program have successfully enrolled over 300,000 Medicare beneficiaries to improve care coordination. In Europe, major players like Bayer and Sanofi focus on comprehensive care models, supported by EU health initiatives aimed at reducing chronic disease prevalence by 20% by 2025. The Asia-Pacific region is witnessing rapid growth, with organizations like Philips launching telehealth services that increased by 140% in usage during the pandemic in countries like Australia. Latin America is also emerging, with initiatives such as Brazil's "Saude na Hora," which aims to provide accessible chronic disease management services across underserved communities. Meanwhile, the Middle East and Africa see increasing investments in healthcare technology, driven by firms like Siemens Healthineers, enhancing access to care and improving management strategies in the region.

Recent Developments:

In January 2024, Amazon launched a chronic condition management program in partnership with Omada Health, connecting users to services for diabetes and weight management. The initiative aims to help consumers access eligible benefits through Amazon's platform, enhancing healthcare accessibility

In February 2022, Teladoc Health launched its Chronic Care Complete program, targeting diabetes, prediabetes, and hypertension management. The initiative includes connected devices, personal health coaches, and mental health support, available through health plans or employers to enhance patient care and management.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Allscripts Healthcare Solutions, Inc.
  • Altruista Health, Inc.
  • Cerner Corporation
  • Cognizant Technology Solutions Corporation
  • Epic Systems Corporation
  • GE Healthcare
  • Health Catalyst, Inc.
  • i2i Population Health
  • IBM Corporation
  • Infosys Limited
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • Medtronic plc
  • Pegasystems Inc.
  • Siemens Healthineers AG
  • ZeOmega, Inc.
  • Others

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY PLATFORM TYPE- MARKET ANALYSIS, 2019 - 2032

  • Web-Based Solutions
  • Cloud-Based Solutions
  • On-Premise Solutions

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Consulting
  • Care Coordination
  • Education & Training
  • Monitoring & Assessment

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Diabetes
  • Cardiovascular Diseases
  • Respiratory Diseases
  • Cancer
  • Others

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Homecare
  • Diagnostic Centers
  • Payers

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Chronic Disease Management Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Chronic Disease Management Market Snippet by Platform Type
    • 2.1.2. Chronic Disease Management Market Snippet by Service Type
    • 2.1.3. Chronic Disease Management Market Snippet by Disease Type
    • 2.1.4. Chronic Disease Management Market Snippet by End-User
    • 2.1.5. Chronic Disease Management Market Snippet by Country
    • 2.1.6. Chronic Disease Management Market Snippet by Region
  • 2.2. Competitive Insights

3. Chronic Disease Management Key Market Trends

  • 3.1. Chronic Disease Management Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Chronic Disease Management Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Chronic Disease Management Market Opportunities
  • 3.4. Chronic Disease Management Market Future Trends

4. Chronic Disease Management Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Chronic Disease Management Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Chronic Disease Management Market Landscape

  • 6.1. Chronic Disease Management Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Chronic Disease Management Market - By Platform Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Platform Type, 2023 & 2032 (%)
    • 7.1.2. Web-Based Solutions
    • 7.1.3. Cloud-Based Solutions
    • 7.1.4. On-Premise Solutions

8. Chronic Disease Management Market - By Service Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Service Type, 2023 & 2032 (%)
    • 8.1.2. Consulting
    • 8.1.3. Care Coordination
    • 8.1.4. Education & Training
    • 8.1.5. Monitoring & Assessment

9. Chronic Disease Management Market - By Disease Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Disease Type, 2023 & 2032 (%)
    • 9.1.2. Diabetes
    • 9.1.3. Cardiovascular Diseases
    • 9.1.4. Respiratory Diseases
    • 9.1.5. Cancer
    • 9.1.6. Others

10. Chronic Disease Management Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals & Clinics
    • 10.1.3. Homecare
    • 10.1.4. Diagnostic Centers
    • 10.1.5. Payers

11. Chronic Disease Management Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Chronic Disease Management Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Chronic Disease Management Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Chronic Disease Management Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Chronic Disease Management Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Chronic Disease Management Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Chronic Disease Management Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Allscripts Healthcare Solutions, Inc.
    • 12.2.2. Altruista Health, Inc.
    • 12.2.3. Cerner Corporation
    • 12.2.4. Cognizant Technology Solutions Corporation
    • 12.2.5. Epic Systems Corporation
    • 12.2.6. GE Healthcare
    • 12.2.7. Health Catalyst, Inc.
    • 12.2.8. i2i Population Health
    • 12.2.9. IBM Corporation
    • 12.2.10. Infosys Limited
    • 12.2.11. Koninklijke Philips N.V.
    • 12.2.12. McKesson Corporation
    • 12.2.13. Medtronic plc
    • 12.2.14. Pegasystems Inc.
    • 12.2.15. Siemens Healthineers AG
    • 12.2.16. ZeOmega, Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us